Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the COVID-19 crisis on imaging in oncological trials.
Deroose CM, Lecouvet FE, Collette L, Oprea-Lager DE, Kunz WG, Bidaut L, Verhoeff JJC, Caramella C, Lopci E, Tombal B, de Geus-Oei LF, Fournier L, Smits M, deSouza NM. Deroose CM, et al. Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2054-2058. doi: 10.1007/s00259-020-04910-y. Eur J Nucl Med Mol Imaging. 2020. PMID: 32533240 Free PMC article. No abstract available.
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.
Van Binnebeek S, Baete K, Vanbilloen B, Terwinghe C, Koole M, Mottaghy FM, Clement PM, Mortelmans L, Haustermans K, Van Cutsem E, Verbruggen A, Bogaerts K, Verslype C, Deroose CM. Van Binnebeek S, et al. Among authors: deroose cm. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1141-57. doi: 10.1007/s00259-013-2670-x. Epub 2014 Mar 26. Eur J Nucl Med Mol Imaging. 2014. PMID: 24668274 Clinical Trial.
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.
Lecouvet FE, Oprea-Lager DE, Liu Y, Ost P, Bidaut L, Collette L, Deroose CM, Goffin K, Herrmann K, Hoekstra OS, Kramer G, Lievens Y, Lopci E, Pasquier D, Petersen LJ, Talbot JN, Zacho H, Tombal B, deSouza NM. Lecouvet FE, et al. Among authors: deroose cm. Lancet Oncol. 2018 Oct;19(10):e534-e545. doi: 10.1016/S1470-2045(18)30571-0. Epub 2018 Oct 1. Lancet Oncol. 2018. PMID: 30303127 Review.
Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.
Levillain H, Duran Derijckere I, Ameye L, Guiot T, Braat A, Meyer C, Vanderlinden B, Reynaert N, Hendlisz A, Lam M, Deroose CM, Ahmadzadehfar H, Flamen P. Levillain H, et al. Among authors: deroose cm. Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2270-2279. doi: 10.1007/s00259-019-04427-z. Epub 2019 Jul 19. Eur J Nucl Med Mol Imaging. 2019. PMID: 31324943
Al18F-NOTA-octreotide: first comparison with 68Ga-DOTATATE in a neuroendocrine tumour patient.
Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Among authors: deroose cm. Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2398-2399. doi: 10.1007/s00259-019-04425-1. Epub 2019 Jul 31. Eur J Nucl Med Mol Imaging. 2019. PMID: 31367905 No abstract available.
Nuclear medicine in precision oncology: a foreword.
de Geus-Oei LF, Deroose CM. de Geus-Oei LF, et al. Among authors: deroose cm. Q J Nucl Med Mol Imaging. 2020 Sep;64(3):231-233. doi: 10.23736/S1824-4785.20.03262-8. Epub 2020 Apr 28. Q J Nucl Med Mol Imaging. 2020. PMID: 32343513 Free article. No abstract available.
Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour.
Pauwels E, Celen S, Vandamme M, Leysen W, Baete K, Bechter O, Bex M, Serdons K, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Among authors: deroose cm. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):313-315. doi: 10.1007/s00259-020-04830-x. Epub 2020 May 8. Eur J Nucl Med Mol Imaging. 2021. PMID: 32385645 No abstract available.
[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients.
Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Among authors: deroose cm. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3033-3046. doi: 10.1007/s00259-020-04918-4. Epub 2020 Jul 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32617641
Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.
Fournier L, Costaridou L, Bidaut L, Michoux N, Lecouvet FE, de Geus-Oei LF, Boellaard R, Oprea-Lager DE, Obuchowski NA, Caroli A, Kunz WG, Oei EH, O'Connor JPB, Mayerhoefer ME, Franca M, Alberich-Bayarri A, Deroose CM, Loewe C, Manniesing R, Caramella C, Lopci E, Lassau N, Persson A, Achten R, Rosendahl K, Clement O, Kotter E, Golay X, Smits M, Dewey M, Sullivan DC, van der Lugt A, deSouza NM, European Society Of Radiology. Fournier L, et al. Among authors: deroose cm. Eur Radiol. 2021 Aug;31(8):6001-6012. doi: 10.1007/s00330-020-07598-8. Epub 2021 Jan 25. Eur Radiol. 2021. PMID: 33492473 Free PMC article.
186 results